| |
| |
| Exchange: |
American Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
41,630,000 |
| Market
Cap: |
26.95(M) |
| Last
Volume: |
204,752 |
Avg
Vol: |
422,654 |
| 52
Week Range: |
$0.6474 - $0.6474 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Lannett primarily develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. Co.'s primary products include: Amphetamine IR Tablets, which are used to treat Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy; Amphetamine ER Capsules, which are indicated for use to treat ADHD; Dicyclomine Tablets, which are indication for the treatment of functional bowel disorder and irritable bowel syndrome; Fluphenazine Tablets, which are used for the management of manifestations of psychotic disorders; and Levothyroxine Capsules, which are soft gel capsules used to treat patients with hypothyroidism and other conditions.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
166,159 |
| Total Buy Value |
$0 |
$0 |
$0 |
$81,668 |
| Total People Bought |
0 |
0 |
0 |
4 |
| Total Buy Transactions |
0 |
0 |
0 |
4 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Farber Jeffrey |
Director |
– • – |
2016-07-22 |
4 |
A |
$0.00 |
$0 |
D/D |
4,075 |
2,441,168 |
|
- |
|
| Paonessa Albert Iii |
Director |
– • – |
2016-07-22 |
4 |
A |
$0.00 |
$0 |
D/D |
4,075 |
7,105 |
|
- |
|
| Maher James M. |
Director |
– • – |
2016-07-22 |
4 |
A |
$0.00 |
$0 |
D/D |
4,075 |
21,798 |
|
- |
|
| Taveira Paul |
Director |
– • – |
2016-07-22 |
4 |
A |
$0.00 |
$0 |
D/D |
4,075 |
24,798 |
|
- |
|
| Farber Jeffrey |
Director |
– • – |
2016-07-06 |
4 |
OE |
$4.55 |
$91,000 |
D/D |
20,000 |
2,437,093 |
|
- |
|
| Ehlinger Robert |
VP and CIO |
• – – |
2016-06-23 |
4 |
AS |
$25.02 |
$524,845 |
D/D |
(20,977) |
19,127 |
|
- |
|
| Ehlinger Robert |
VP and CIO |
• – – |
2016-06-22 |
4 |
AS |
$25.12 |
$406,040 |
D/D |
(16,164) |
40,104 |
|
- |
|
| Ehlinger Robert |
VP and CIO |
• – – |
2016-06-20 |
4 |
AS |
$25.40 |
$1,596,619 |
D/D |
(62,859) |
56,268 |
|
- |
|
| Smith Kevin |
VP of Sales and Marketing |
• – – |
2016-04-24 |
4 |
D |
$20.37 |
$6,661 |
D/D |
(327) |
15,901 |
|
- |
|
| Galvan Martin P |
VP of Finance & CFO |
• – – |
2016-04-24 |
4 |
D |
$20.37 |
$6,681 |
D/D |
(328) |
38,069 |
|
- |
|
| Landis G. Michael |
Principal Accounting Officer |
• – – |
2016-04-24 |
4 |
D |
$20.37 |
$346 |
D/D |
(17) |
1,613 |
|
- |
|
| Bedrosian Arthur P |
CEO |
• • – |
2016-04-24 |
4 |
D |
$20.37 |
$13,811 |
D/D |
(678) |
617,971 |
|
- |
|
| Abt John |
Vice President of Quality |
• – – |
2016-03-30 |
4 |
D |
$17.69 |
$5,219 |
D/D |
(295) |
5,158 |
|
- |
|
| Ehlinger Robert |
VP of Logistics and CIO |
• – – |
2016-03-01 |
4 |
S |
$25.41 |
$1,759,566 |
D/D |
(69,247) |
118,760 |
|
- |
|
| Ehlinger Robert |
VP of Logistics and CIO |
• – – |
2016-03-01 |
4 |
OE |
$3.55 |
$492,983 |
D/D |
65,090 |
188,007 |
|
- |
|
| Dedhiya Mahendra |
Chief Scientific Affairs |
• – – |
2016-02-05 |
4 |
B |
$24.84 |
$24,840 |
D/D |
1,000 |
1,000 |
2.74 |
- |
|
| Bedrosian Arthur P |
CEO |
• • – |
2016-02-05 |
4 |
B |
$24.91 |
$112,095 |
D/D |
4,500 |
618,016 |
2.81 |
- |
|
| Taveira Paul |
Director |
– • – |
2016-02-05 |
4 |
B |
$23.60 |
$23,600 |
D/D |
1,000 |
20,723 |
2.39 |
- |
|
| Galvan Martin P |
VP of Finance & CFO |
• – – |
2016-02-05 |
4 |
B |
$24.65 |
$73,950 |
D/D |
3,000 |
38,397 |
2.74 |
- |
|
| Paonessa Albert Iii |
Director |
– • – |
2016-02-05 |
4 |
B |
$24.57 |
$61,425 |
D/D |
2,500 |
3,030 |
2.39 |
- |
|
| Farber Jeffrey |
Director |
– • – |
2016-02-05 |
4 |
B |
$24.48 |
$122,400 |
D/D |
5,000 |
2,417,093 |
2.39 |
- |
|
| Smith Kevin |
VP of Sales and Marketing |
• – – |
2016-02-05 |
4 |
B |
$24.75 |
$37,125 |
D/D |
1,500 |
15,735 |
2.74 |
- |
|
| Drabik David A |
Director |
– • – |
2016-02-05 |
4 |
B |
$24.74 |
$31,593 |
D/D |
1,277 |
20,500 |
2.39 |
- |
|
| Maher James M. |
Director |
– • – |
2016-02-05 |
4 |
B |
$23.87 |
$23,870 |
D/D |
1,000 |
17,723 |
2.39 |
- |
|
| Bedrosian Arthur P |
CEO |
• • – |
2016-01-12 |
4 |
D |
$35.67 |
$279,510 |
D/D |
(7,836) |
613,516 |
|
- |
|
762 Records found
|
|
Page 15 of 31 |
|
|
